Table 1.
Summary of differentially expressed spots and proteins in IBV ck/CH/LDL/97I, H120, NDV La Sota, and AIV H9 infected groups and between IBV ck/CH/LDL/97I and H120‐infected groups
| IBV ck/CH/LDL/97I/control | IBV H120/control | NDV La Sota/control | AIV H9/control | IBV ck/CH/LDL/97I/ H120 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Spots | Proteins | Spots | Proteins | Spots | Proteins | Spots | Proteins | Spots | Proteins | |
| Totala | 72 | 44 | 65 | 39 | 63 | 41 | 86 | 48 | 63 | 38 |
| Upregulatedb | 26 | 19 | 20 | 15 | 38 | 27 | 39 | 30 | 39 | 28 |
| Downregulatedc | 46 | 29 | 45 | 28 | 25 | 21 | 47 | 25 | 24 | 17 |
a
Total number of differentially expressed spots and protein.
b
Number of upregulated spots and proteins.
c
Number of downregulated spots and proteins.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.